BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 9988811)

  • 1. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year.
    Foulon W; Villena I; Stray-Pedersen B; Decoster A; Lappalainen M; Pinon JM; Jenum PA; Hedman K; Naessens A
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):410-5. PubMed ID: 9988811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Postnatal follow-up of infants born to mothers with certain Toxoplasma gondii infection: evaluation of prenatal management].
    Di Carlo P; Mazzola A; Romano A; Schimmenti MG; Colicchia P; Bellipanni P; Titone L
    Infez Med; 2005 Jun; 13(2):72-8. PubMed ID: 16220026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of congenital toxoplasmosis.
    Foulon W; Naessens A; Ho-Yen D
    J Perinat Med; 2000; 28(5):337-45. PubMed ID: 11125923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.
    Mandelbrot L; Kieffer F; Sitta R; Laurichesse-Delmas H; Winer N; Mesnard L; Berrebi A; Le Bouar G; Bory JP; Cordier AG; Ville Y; Perrotin F; Jouannic JM; Biquard F; d'Ercole C; Houfflin-Debarge V; Villena I; Thiébaut R;
    Am J Obstet Gynecol; 2018 Oct; 219(4):386.e1-386.e9. PubMed ID: 29870736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital toxoplasmosis after a preconceptional or periconceptional maternal infection.
    Robert-Gangneux F; Yera H; D'Herve D; Guiguen C
    Pediatr Infect Dis J; 2009 Jul; 28(7):660-1. PubMed ID: 19561432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid.
    Gratzl R; Hayde M; Kohlhauser C; Hermon M; Burda G; Strobl W; Pollak A
    Eur J Clin Microbiol Infect Dis; 1998 Dec; 17(12):853-8. PubMed ID: 10052549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France.
    Gilbert RE; Gras L; Wallon M; Peyron F; Ades AE; Dunn DT
    Int J Epidemiol; 2001 Dec; 30(6):1303-8. PubMed ID: 11821334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Toxoplasma gondii infection during pregnancy.
    Montoya JG; Remington JS
    Clin Infect Dis; 2008 Aug; 47(4):554-66. PubMed ID: 18624630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital toxoplasmosis: efficacy of maternal treatment with spiramycin alone.
    Vergani P; Ghidini A; Ceruti P; Strobelt N; Spelta A; Zapparoli B; Rescaldani R
    Am J Reprod Immunol; 1998 May; 39(5):335-40. PubMed ID: 9602252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii.
    Gilbert R; Gras L;
    BJOG; 2003 Feb; 110(2):112-20. PubMed ID: 12618153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.
    Bessières MH; Berrebi A; Rolland M; Bloom MC; Roques C; Cassaing S; Courjault C; Séguéla JP
    Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):37-45. PubMed ID: 11134824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of toxoplasmosis in the pregnant mother and newborn child.
    Stray-Pedersen B
    Scand J Infect Dis Suppl; 1992; 84():23-31. PubMed ID: 1290070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Toxoplasma infections in early pregnancy: consequences and management].
    Wallon M; Gaucherand P; Al Kurdi M; Peyron F
    J Gynecol Obstet Biol Reprod (Paris); 2002 Sep; 31(5):478-84. PubMed ID: 12379832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of toxoplasmosis.
    Montoya JG; Rosso F
    Clin Perinatol; 2005 Sep; 32(3):705-26. PubMed ID: 16085028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of spiramycin in prevention of fetal toxoplasmosis.
    Avci ME; Arslan F; Çiftçi Ş; Ekiz A; Tüten A; Yildirim G; Madazli R
    J Matern Fetal Neonatal Med; 2016; 29(13):2073-6. PubMed ID: 26365472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
    Mazzola A; Casuccio A; Romano A; Schimmenti MG; Titone L; Di Carlo P
    Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of congenital toxoplasmosis in France: current data].
    Garcia-Méric P; Franck J; Dumon H; Piarroux R
    Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoplasmosis in pregnancy.
    Wong SY; Remington JS
    Clin Infect Dis; 1994 Jun; 18(6):853-61; quiz 862. PubMed ID: 8086543
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women.
    Lefevre-Pettazzoni M; Bissery A; Wallon M; Cozon G; Peyron F; Rabilloud M
    Clin Vaccine Immunol; 2007 Mar; 14(3):239-43. PubMed ID: 17202303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters.
    Foulon W; Pinon JM; Stray-Pedersen B; Pollak A; Lappalainen M; Decoster A; Villena I; Jenum PA; Hayde M; Naessens A
    Am J Obstet Gynecol; 1999 Oct; 181(4):843-7. PubMed ID: 10521739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.